MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis

Journal of Neuroimaging

Volumn 21, Issue 3, 2011, Pages 303-305

  Zouvelou, Vasiliki ^a   Rentzos, Michael ^a   Toulas, Panagiotis ^b   Evdokimidis, Ioannis ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b Institute Euromedica Encephalos   (Greece)

Author keywords

MRI; Muscle atrophy; MuSK myasthenia

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DELTOID MUSCLE; DIAGNOSTIC VALUE; DIPLOPIA; DISEASE DURATION; DYSARTHRIA; FEMALE; HUMAN; MEDICAL HISTORY; MUSCLE ATROPHY; MUSCLE SPECIFIC TYROSINE KINASE MYASTHENIA GRAVIS; MYASTHENIA GRAVIS; NERVE STIMULATION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; ORBICULARIS OCULI MUSCLE; PTOSIS; TRANSCUTANEOUS NERVE STIMULATION;

FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MUSCULAR ATROPHY; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; YOUNG ADULT;

EID: 79959704101     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2009.00456.x     Document Type: Article

References (9)

1. Hoch W, McConville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-368.
2. Scuderi F, Marino M, Colonna L, et al. Anti-P110 autoantibodies identify a subtype of 'seronegative' myasthenia gravis with prominent oculobulbar involvement. Lab Invest 2002;82:1139-1146.
3. Vincent A, Bowen J, Newsom-Davis J, et al. Seronegative generalized myasthenia gravis: clinical features, antibodies and their targets. Lancet Neurol 2003;2:99-106.
4. Wolfe GI, Oh SJ. Clinical phenotype of muscle-specific Tyrosine kinase-antibody-positive Myasthenia Gravis. Ann NY Acad Sci 2008;1132:71-75.
5. Vincent A, Leite MI. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 2005;18:519-525.
6. Farrugia ME, Robson M, Clover L, et al. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain 2006;129:1481-1492.
7. Benveniste O, Jacobson L, Farrugia ME, et al. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo. J Neuroimmunol 2005;170:41-48.
8. Boneva N, Frenkian-Cuvelier M, Bidault J, et al. Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis. J Neuroimmunol 2006;177:119-131.
9. Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy related-ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004;117:399-412.